Back to FDA Applications sponsored by FRESENIUS KABI USA

FDA Drug Application 040263 by FRESENIUS KABI USA

Application Number040263
Application Type Abbreviated New Drug Application
Sponsor ApplicantFRESENIUS KABI USA
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type
Therapeutic Potential
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP02/26/1999N514000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/40263ltr.pdf 2/26/1999
AP02/26/1999N6243000   http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/040263_methotrexate_toc.cfm 7/31/2003
AP02/26/1999N9209000   http://www.accessdata.fda.gov/drugsatfda_docs/anda/99/40263_Methotrexate_Prntlbl.pdf 6/9/2004
AP012/2/2002SCS       




Back to FDA Applications sponsored by FRESENIUS KABI USA